SUBMISSION WRITING SERVICES
BioBoston CRO provides regulatory submission writing services for sponsors that need clear, source-supported application documents developed through a controlled authoring and review process. Support can cover a defined Common Technical Document module, an application document set, a response package, targeted document rescue, or independent quality review.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Add experienced writing capacity for defined application documents and Common Technical Document content while sponsor regulatory leaders retain strategy and approval authority.
Create a source map, content plan, open-item process, and cross-functional review model before several writers and reviewers produce inconsistent narratives.
Assess existing drafts, unresolved comments, data changes, document interfaces, and milestone risk before resetting the authoring plan.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Kick off the authoring workstream and confirm the application context, documents, source owners, milestone, responsibilities, and review model.
2. Assess the source package and current drafts; create the content plan, source map, authoring schedule, and open-item tracker.
3. Draft the assigned documents or modules in controlled sections while tracking assumptions, questions, data changes, and dependencies.
4. Coordinate consolidated cross-functional review and route decisions to the designated regulatory, clinical, technical, safety, quality, and statistical owners.
5. Resolve comments, perform document and cross-document quality checks, and prepare clean and redline versions.
6. Support sponsor approval, publishing handoff, response preparation, or subsequent document updates as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Define submission strategy, sequencing, content inventory, responsibilities, readiness, and application management before and during authoring.
Develop integrated safety, efficacy, performance, or clinical-evidence summaries from approved analyses and source documents.
Develop complete study reports that may serve as important submission sources and support cross document consistency.
Clarify classification, pathway, evidence implications, and authority strategy that determine the submission route.
Expertise
Submission-writing experience should match the application type, modules or documents, product, development stage, source complexity, review environment, and publishing interface.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
Use this IND submission checklist to confirm content owners, source documents, evidence, red flags, and authoring readiness before writing begins.
A planned guide to document ownership, clinical and nonclinical sources, CMC interfaces, open items, and review cycles.
A planned tool for product descriptions, terminology, data cutoffs, study references, claims, commitments, and cross-document changes.
This decision guide explains what each controls, what FDA expects for commercial INDs, and what early-stage sponsors should resolve before submission writing begins.
FAQs
Submission Planning owns regulatory strategy, sequencing, content inventory, readiness, responsibilities, and application management. Submission Writing owns authoring and development of the documents and Common Technical Document modules defined by that plan.
Yes. A focused engagement can cover one module, summary, response, section, or document set if the regulatory position, sources, interfaces, reviewers, and downstream dependencies are clearly defined.
Yes. A rescue engagement should begin with a structured assessment of the drafts, source traceability, comments, data changes, document interfaces, open decisions, and remaining milestone.
This page covers submission-document authoring and publishing handoff. Any specific electronic publishing, validation, gateway, or software capability must be separately confirmed before it is represented as part of the service.
Sources depend on the document, but may include plans, protocols, reports, analyses, CMC documents, nonclinical reports, safety information, authority correspondence, prior submissions, product information, and approved data cutoffs.
No. Writing support can improve clarity, traceability, consistency, and readiness, but the sponsor is responsible for its submission and authorities determine filing, review questions, and outcomes.
PROJECT FORM
Share the application type, documents or modules, current draft stage, source readiness, review team, and target milestone. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the application, documents in scope, source package, current drafts, review owners, publishing interface, and target milestone. BioBoston can then define the writing role, work plan, quality controls, and related regulatory dependencies
